                               SEQUENCE LISTING

<110> THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
 
<120> METHODS OF DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE

<130> UCDVP141WO

<140> PCT/US2017/058039
<141> 2017-10-24

<150> 62/412,684
<151> 2016-10-25

<160> 10    

<170> PatentIn version 3.5

<210> 1
<211> 175
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 1
cacgttttgg tgcgaagtct atttccacta tcgcagaatc aaaacgtttt ccgctgcacg       60

aaatgcgcga cgatgtcgca ttccagatta tcaatgacga attatatctt gatggcaacg      120

ctcgtcagaa cctggccact ttctgccaga cttgggacga cgaaaatgtc cacaa           175


<210> 2
<211> 175
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 2
cacgttttgg tgcgaagtct atttccacta tcgcagaatc aaaacgtttt ccgctgcacg       60

aaatgcgcga cgatgtcgca ttccagatta tcaatgacga attatatctt gatggcaacg      120

ctcgtcagaa cctggccact ttctgccaga cctgggacga cgaaaatgtc cacaa           175


<210> 3
<211> 175
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 3
cacgttttgg tgcgaagtct atttccacta tcgcagaatc aaaacgtttt ccgctgcacg       60

aaatgcgcga cgatgtcgca ttccagatta tcaatgacga attatatctt gatggcaacg      120

ctcgtcagaa cctggccact ttctgccaga cctgggacga cgaaaatgtc cacaa           175


<210> 4
<211> 175
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 4
cacgttttgg tgcgaagtct atttccacta tcgcagaatc aaaacgtttt ccgctgcacg       60

aaatgcgcga cgatgtcgca ttccagatta tcaatgacga attatatctt gatggcaacg      120

ctcgtcagaa cctggccact ttctgccaga cctgggacga cgaaaatgtc cacaa           175


<210> 5
<211> 175
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 5
cacgttttgg tgcgaagtct atttccacta tcgcagaatc aaaacgtttt ccgctgcacg       60

aaatgcgcga cgatgtcgca ttccagatta tcaatgacga attatatctt gatggcaacg      120

ctcgtcagaa cctagccact ttctgccaga cttgggacga cgaaaatgtc cacaa           175


<210> 6
<211> 175
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 6
cacgttttgg tgcgaagtct atttccacta tcgcagaatc aaaacgtttt ccgctgcacg       60

aaatgcgcga cgatgtcgca ttccagatta tcaatgacga attatatctt gatggcaacg      120

ttcgtcagaa cctggccact ttctgccaga cctgggacga cgaaaatgtc cacaa           175


<210> 7
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 7
cagaatccat tgcccggtga                                                   20


<210> 8
<211> 22
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 8
ccatgtcaca cttttcgcat ct                                                22


<210> 9
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 9
cacgttttgg tgcgaagtct                                                   20


<210> 10
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 10
ttgtggacat tttcgtcgtc                                                   20

